Hepatitis B Virus (HBV) Infection Market Insights, Epidemiology and Market Forecast-2028

Hepatitis B Virus (HBV) Infection Market Insights, Epidemiology and Market Forecast-2028

  • Pages: 120
  • Geography: Global
  • Delivery Timeline: 7-10 business days
  • Publication: Dec, 2019
  • SKU: DIMI0581
  • Single User License
    (20% Off)
    $6250
  • Site License
    (30% Off)
    $12500
  • Global License
    (40% Off)
    $18750
Request Sample

Name*  
Email ID*  
Mobile*  
Company*  
Country*  
Zip Code*  
Address*  
Message*  
X

Request Sample Pages

Request Before Buy
Name*  
Email ID*  
Mobile*  
Company*  
Message*  
X

Inquire Before Buy

Send Friend
Name*  
Email ID*  
Mobile*  
Company*  
Message*  
X

Send to Friend

Hepatitis B Virus (HBV) Infection Market Insights, Epidemiology and Market Forecast-2028

Hepatitis B Infection overview

Hepatitis B is a life-threatening liver infection that is caused by the Hepatitis B Virus (HBV). It is a chief global health problem and it can be an acute infection or a chronic infection. Chronic HBV infection is a leading cause of chronic hepatitis and advanced-stage liver diseases, including cirrhosis and hepatocellular carcinoma.

Hepatitis B virus a blood-borne and sexually transmitted virus that is acquired by percutaneous and mucosal open to blood or other body fluids of an infected person. Clinical manifestations of hepatitis from different origins may be quite similar.

Most people do not experience any symptom during the acute infection phase. However, some people have acute illness with symptoms that last several weeks, including yellowing of the skin and eyes (jaundice), dark urine, extreme fatigue, nausea, vomiting, and abdominal pain.

DelveInsight's “Hepatitis B Virus Market Insights, Epidemiology and Market Forecast – 2028” report provides the detailed Hepatitis B virus overview and in depth understanding of historical and forecasted Hepatitis B virus epidemiology. It highlights the existing Hepatitis B virus treatment patterns, potential upcoming drugs and also identifies best of the Hepatitis B virus market opportunities by providing the current and forecasted market revenue, sales trends, and drug uptake during the study period from 2017-2028.

Hepatitis B Virus Epidemiology 

1. Hepatitis B virus Infection is estimated to have 786,000 deaths and the vast majority being attributable to liver cancer (341,000 deaths) and cirrhosis (312,000 deaths).

2. Approximately 2 billion people gloablly has been infected with the Hepatitis B Virus and about 360 million live with chronic Hepatitis B infection.

3. The Hepatitis B virus prevalence in the general population is heterogeneous in Europe ranging 0.1-7 % depending on the country.

The Hepatitis B virus epidemiology report section has all possible division to give a better understanding about the Hepatitis B virus market scenario in 7MM. It also helps to recognize the Hepatitis B virus causes of present and forecasted trends by interpreting numerous studies, survey reports and views of key opinion leaders. The Hepatitis B virus report also proffers total diagnosed incident population, incident population, overall incidence, Type-Specific Diagnosed Incident cases, Gender-Specific Diagnosed Incident Cases, Biomarker Specific Diagnosed Incident Cases and Age Specific Diagnosed Incident Cases.

Hepatitis B Virus Understanding and Treatment Algorithm

The Hepatitis B virus report provides the in-depth analysis of the disease overview by providing details such as disease definition, classification, symptoms, etiology, pathophysiology and diagnostic trends. The comprehensive details about Hepatitis B virus treatment algorithms and treatment guidelines for Hepatitis B in the US, Europe, and Japan are also given in the report. 

Hepatitis B Virus Market Outlook

The Hepatitis B Virus market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the Hepatitis B Virus market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. This segment analyses the Hepatitis B Virus market trend of each marketed drug and late-stage pipeline drugs. 

The key players that are developing Hepatitis B Virus drugs are:-

  • Ascentage Pharma
  • Replicor
  • Ionis Pharma
  • Gilead Sciences
  • Arbutus Biopharma
  • Spring Bank Pharmaceuticals
  • MYR Pharma
  • GC Pharma
  • Altimmune

And many others

Hepatitis B Virus Market Share by Therapies

This section aims at the rate of uptake of the potential drugs lately launched or will be launched in the Hepatitis B Virus market during the study period from 2017-2028. The analysis covers Hepatitis B Virus drug market uptake; patient uptake by therapies and sales of each drug. This information also helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It provides the comparison of the drugs on the basis of market share and size. This analysis helps in investigating factors important in market uptake and in making financial as well as regulatory decisions.

The anticipated launch of emerging therapies, such as APG-1387 (Ascentage Pharma) REP 2139 (Replicor), IONIS-HBVRx (Ionis Pharma), Myrcludex B (MYR Pharma), and Inarigivir – as a monotherapy and coadministration with Gilead’s Vemlidy or with NUC’s (Spring Bank Pharmaceuticals) may change the Hepatitis B virus market scenario of in the upcoming years.

Key Benefits of Hepatitis B Virus Report 

  • DelveInsight’s report will help to develop Business Strategies by understanding the trends shaping and driving the Hepatitis B Virus market.
  • Organize sales and marketing efforts by recognising the best opportunities for Hepatitis B Virus market.
  • To comprehend the future market competition in the Hepatitis B Virus market.
  • Identify emerging players with potentially dominant product portfolios and create effective counter-strategies to garner a competitive advantage. 

Hepatitis B Virus Report Insights

  • Hepatitis B Virus epidemiology segmentation
  • Hepatitis B Virus classification
  • Therapeutic Approaches in Hepatitis B Virus 
  • Hepatitis B Virus Pipeline Analysis
  • Hepatitis B Virus Market Size and Trends
  • Hepatitis B Virus Market Opportunities
  • Impact of upcoming Therapies in Hepatitis B Virus  

Hepatitis B Virus Report Key Strengths

  • 10 Year Forecast (2017-2028)
  • 7MM Coverage (The United States; EU5- Germany, France, Italy, Spain and United Kingdom; and Japan)
  • Historical and forecasted Epidemiology 
  • Age specific segmentation and gender specific segmentation
  • Drugs Uptake
  • Highly Analyzed Market
  • Key Cross Competition 

1. Report Introduction
2. Hepatitis B Virus (HBV) Infection Market Overview at a Glance
2.1. Market Share Distribution of Hepatitis B Virus (HBV) Infection in 2017
2.2. Market Share Distribution of Hepatitis B Virus (HBV) Infection in 2028
3. Disease Background and Overview: Hepatitis B Virus (HBV) Infection
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Hepatitis B Virus (HBV) Infection in 7MM
4.3. Total Prevalent  Patient Population of Hepatitis B Virus (HBV) Infection in 7MM – By Countries
5. Epidemiology of Hepatitis B Virus (HBV) Infection by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection
5.1.3. Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection *Indication Specific
5.1.4. Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection*Indication Specific
5.1.5. Diagnosed Cases of the Hepatitis B Virus (HBV) Infection
5.1.6. Treatable Cases of the Hepatitis B Virus (HBV) Infection
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection
5.4.3. Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection*

5.4.4. Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection*

5.4.5. Diagnosed Cases of the Hepatitis B Virus (HBV) Infection
5.4.6. Treatable Cases of the Hepatitis B Virus (HBV) Infection
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection
5.5.3. Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection*

5.5.4. Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection*

5.5.5. Diagnosed Cases of the Hepatitis B Virus (HBV) Infection
5.5.6. Treatable Cases of the Hepatitis B Virus (HBV) Infection
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection
5.6.3. Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection*

5.6.4. Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection*

5.6.5. Diagnosed Cases of the Hepatitis B Virus (HBV) Infection
5.6.6. Treatable Cases of the Hepatitis B Virus (HBV) Infection
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection
5.7.3. Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection*

5.7.4. Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection*

5.7.5. Diagnosed Cases of the Hepatitis B Virus (HBV) Infection
5.7.6. Treatable Cases of the Hepatitis B Virus (HBV) Infection
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection
5.8.3. Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection*

5.8.4. Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection*

5.8.5. Diagnosed Cases of the Hepatitis B Virus (HBV) Infection
5.8.6. Treatable Cases of the Hepatitis B Virus (HBV) Infection
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection
5.9.3. Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection*

5.9.4. Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection*

5.9.5. Diagnosed Cases of the Hepatitis B Virus (HBV) Infection
5.9.6. Treatable Cases of the Hepatitis B Virus (HBV) Infection
6. Current Treatment & Medical practices
6.1. Treatment Algorithm
6.2. Treatment Guidelines
7. Unmet Needs of the Hepatitis B Virus (HBV) Infection
8. Marketed Therapies 
8.1. Drug A: Company 1
8.1.1. Drug Description
8.1.2. Mechanism of Action
8.1.3. Regulatory Milestones
8.1.4. Advantages & Disadvantages
8.1.5. Product Profile
8.2. Drug B: Company 2
8.2.1. Drug Description
8.2.2. Mechanism of Action
8.2.3. Regulatory Milestones
8.2.4. Advantages & Disadvantages
8.2.5. Product Profile
9. Pipeline Therapies – At a glance
10. Key Cross Competition
11. Emerging Therapies for Hepatitis B Virus (HBV) Infection
11.1. Drug C: Company 3
11.1.1. Drug Description
11.1.2. Clinical Trials Details
11.1.3. Safety and Efficacy Profile
11.1.4. Advantages & Disadvantages  
11.1.5. Pipeline Development Activities
11.1.6. Product Profile
11.2. Drug D: Company 4
11.2.1. Drug Description
11.2.2. Clinical Trials Details
11.2.3. Safety and Efficacy Profile
11.2.4. Advantages & Disadvantages  
11.2.5. Pipeline Development Activities
11.2.6. Product Profile
12. Hepatitis B Virus (HBV) Infection: 7MM Market Analysis
12.1. 7MM Market Size of Hepatitis B Virus (HBV) Infection
12.2. 7MM Percentage Share of drugs marketed for Hepatitis B Virus (HBV) Infection
12.3. 7MM Market Sales of Hepatitis B Virus (HBV) Infection by Products
13. Hepatitis B Virus (HBV) Infection: Country-Wise Market Analysis
13.1. United States
13.1.1. Market Size of Hepatitis B Virus (HBV) Infection in United States
13.1.2. Percentage Share of drugs marketed for Hepatitis B Virus (HBV) Infection in United States
13.1.3. Market Sales of Hepatitis B Virus (HBV) Infection by Products in United States
13.1.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2. EU-5
13.2.1. Germany
13.2.1.1. Market Size of Hepatitis B Virus (HBV) Infection in Germany
13.2.1.2. Percentage Share of drugs marketed for Hepatitis B Virus (HBV) Infection in Germany
13.2.1.3. Market Sales of Hepatitis B Virus (HBV) Infection by Products in Germany
13.2.1.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.2. France
13.2.2.1. Market Size of Hepatitis B Virus (HBV) Infection in France
13.2.2.2. Percentage Share of drugs marketed for Hepatitis B Virus (HBV) Infection in France
13.2.2.3. Market Sales of Hepatitis B Virus (HBV) Infection by Products in France
13.2.2.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.3. Italy
13.2.3.1. Market Size of Hepatitis B Virus (HBV) Infection in Italy
13.2.3.2. Percentage Share of drugs marketed for Hepatitis B Virus (HBV) Infection in Italy
13.2.3.3. Market Sales of Hepatitis B Virus (HBV) Infection by Products in Italy
13.2.3.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.4. Spain
13.2.4.1. Market Size of Hepatitis B Virus (HBV) Infection in Spain
13.2.4.2. Percentage Share of drugs marketed for Hepatitis B Virus (HBV) Infection in Spain
13.2.4.3. Market Sales of Hepatitis B Virus (HBV) Infection by Products in Spain
13.2.4.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.5. United Kingdom
13.2.5.1. Market Size of Hepatitis B Virus (HBV) Infection in United Kingdom
13.2.5.2. Percentage Share of drugs marketed for Hepatitis B Virus (HBV) Infection in United Kingdom
13.2.5.3. Market Sales of Hepatitis B Virus (HBV) Infection by Products in United Kingdom
13.2.5.4. Analysis of Upcoming Therapies and their Impact on the Market
13.3. Japan
13.3.1. Market Size of Hepatitis B Virus (HBV) Infection in Japan
13.3.2. Percentage Share of drugs marketed for Hepatitis B Virus (HBV) Infection in Japan
13.3.3. Market Sales of Hepatitis B Virus (HBV) Infection by Products in Japan
13.3.4. Analysis of Upcoming Therapies and their Impact on the Market
14. Market Drivers
15. Market Barriers
16. Appendix
17. Report Methodology
17.1. Sources
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Figure 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Figure 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Figure 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Figure 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Figure 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Table 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Table 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Table 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 17: Treatable Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Table 18: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 19: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 20: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 21: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 22: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Italy (2017-2028)

Table 23: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 24: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 25: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 26: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 27: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Spain (2017-2028)

Table 28: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 29: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 30: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 31: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 32: Treatable Cases of the Hepatitis B Virus (HBV) Infection in UK (2017-2028)

Table 33: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 34: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 35: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 36: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 37: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Japan (2017-2028)

Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 42:7MM- Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 43:7MM- Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 44: United States-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 45: United States-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 46: United States-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 47: Germany-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 48: Germany-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 49: Germany-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 50: France-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 51: France-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 52: France-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 53: Italy-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 54: Italy-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 55: Italy-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 56: Spain-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 57: Spain-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 58: Spain-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 59:UK-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 60:UK-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 61:UK-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 62: Japan-Market Size of Hepatitis B Virus (HBV) Infection in USD MM (2017-2028)

Table 63: Japan-Market Share Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

Table 64: Japan-Market Sales of Hepatitis B Virus (HBV) Infection by Therapies in USD MM (2017-2028)

 

Figure 1: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 4: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 5: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 6: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 7: Treatable Cases of the Hepatitis B Virus (HBV) Infection in United States (2017-2028)

Figure 8: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 9: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 10: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 11: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 12: Treatable Cases of the Hepatitis B Virus (HBV) Infection in Germany (2017-2028)

Figure 13: Prevalent/Incident Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 14: Sub-Type Specific cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 15: Sex- Specific Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 16: Diagnosed Cases of the Hepatitis B Virus (HBV) Infection in France (2017-2028)

Figure 17: Treatable Cases o